2 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Carcinoma, Acinar Cell: new trials by email Literature Review of Carcinoma, Acinar Cell trials Research Report on Carcinoma, Acinar Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors ART0380, Gemcitabine, Irinotecan - Advanced Cancer, Metastatic Cancer | Phase 1 / Phase 2 | Recruiting | Artios Pharma Ltd | 542 | 2021-01-27 | 2026-10-22 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) P-PSMA-101 CAR-T cells, Rimiducid - Prostatic Neoplasms, Castration-Resistant, Neoplasms by Histologic Type | Phase 1 | Terminated | Poseida Therapeutics, Inc. | 40 | 2020-02-28 | 2025-02-17 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer Pancreatectomy, Lavage - Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma | Not applicable | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 845 | 2016-04-27 | 2026-05-29 |
Carcinoma, Adenoid Cystic (2) · Cholangiocarcinoma (2) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Mucinous (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Carcinoma, Basal Cell (1) · Carcinoma, Endometrioid (1) · Carcinoma, Giant Cell (1) · Carcinoma, Mucoepidermoid (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1) · Chordoma (1) · Colorectal Neoplasms (1)
Adenocarcinoma (4) · Carcinoma (4) · Neoplasms, Glandular and Epithelial (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Adnexal Diseases (2)
CTLA-4 Antigen (1) · Gemcitabine (1) · Ipilimumab (1) · Irinotecan (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Pancreatectomy (1) · Specimen Handling (1) · Therapeutic Irrigation (1)
Artios Pharma Ltd (1) · National Cancer Institute (NCI) (1) · Poseida Therapeutics, Inc. (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (4) · France (1) · Guam (1) · Spain (1) · United Kingdom (1)
Antonio Gonzalez, MD, PHD (1) · Harish Lavu, MD (1) · Kim Reiss Binder, MD (1) · Melissa Johnson, MD (1) · Rajesh Belani, M.D. (1) · Sandip P Patel (1) · Susanna Ulahannan, MD (1)
PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
U10CA180888 (1)